Antitumor antibiotic BMS-199687
AssigneeBristol-Myers Squibb Company
InventorsMitsuaki Tsunakawa, Li-Ping Chang, Stephen W. Mamber, Isia Bursuker, Robert Hugill
Life of this patent
Estimating the term…
Abstract
The present invention relates to the novel antitumor antibiotic designated BMS-199687 and to its preparation. The compound is obtained by culturing a new strain of Actinomadura ferruginea. BMS-199687 demonstrates antitumor activity in standard antitumor animal model systems.
Claims3
A process for the preparation of BMS-199687 having the formula ##STR2## which comprises cultivating a BMS-199687-producing strain of Actinomadura ferruginea in an aqueous nutrient medium containing assimilable sources of carbon and nitrogen under submerged aerobic conditions until a substantial amount of BMS-199687 is produced by said organism in such culture medium and then recovering said BMS-199687 from the culture medium.
A biologically pure culture of the microorganism Actinomadura ferruginea strain WC57581 (ATCC-55733) which is capable of producing the antibiotic BMS-199687 of the formula ##STR3## in a recoverable quantity upon cultivation in a culture medium containing assimilable sources of carbon and nitrogen under submerged aerobic conditions.
Dependencies are inferred from the claim text.